Office of Research & Development |
|
Project Number: | 2015 |
Title: | CSP #2015 - Multicenter, Randomized, Double-blind Comparator Study of Antipsychotics Pimavanserin and Quetiapine for Parkinson’s Disease Psychosis (C-SAPP) |
Principal Investigator: | Daniel Weintraub |
Location: | Philadelphia, PA |
Research Service: | Cooperative Studies |
Project Period: | January 2020 - September 2027 |
FY 2024 Funding Amount: | $3,103,073 |
Abstract: | See Cooperative Studies Program (CSP) for details on active studies, approved studies, studies in planning, centers, etc. |